Please see the left column of this page for downloadable materials from the event.
Engredea is the definitive trade show that encompasses the world of ingredients. Co-located with Natural Products Expo West, Engredea brings together a global community of leading suppliers and manufacturers to source new ingredients, packaging, technologies, equipment, and services in the nutrition industry.
Venable’s Food and Drug, Advertising and Marketing, and Intellectual Property attorneys, who rank among the nation’s top legal thought leaders with decades of FDA and marketplace experience, will be on-hand to exchange ideas and provide legal and regulatory insights.
Connect with Venable attorneys on the Engredea exhibit show floor at booth #262.
Also, be sure to join Venable partners Todd A. Harrison and Claudia A. Lewis for an informative panel discussion on product claims.
Friday, March 7, 2014
1:30 p.m. – 2:30 p.m. PT
Anaheim Marriott – Grand Salon AB
Session Title: Give Me a Break, Is That Really a Disease Claim?
Speakers:
|
Todd A. Harrison |
Claudia A. Lewis |
Description: Let's face it, if you want to sell your product you will need to make a claim about it. However, a claim is in the eye of the beholder and can have varying meanings depending on who is looking. You may be able to say more than you think. Join Venable partners Todd A. Harrison and Claudia A. Lewis, along with Najla Guthrie, CEO of KGK Synergize, as they explore how the FDA, FTC, and other key government regulatory bodies review and evaluate claims.
During this interactive presentation, attendees will learn:
- Key components that comprise a claim
- How the FDA, FTC, and other government regulatory bodies evaluate claims
- How to effectively design clinical trials around claims
- Practical tips to evaluate and conduct a risk/benefit analysis when creating claims
In addition to Venable speakers Todd A. Harrison and Claudia A. Lewis, the following Venable thought leaders will also be present at Engredea: Michelle C. Jackson, Heili Kim, Stefan J. Kirchanski, Miguel A. Lopez, John G. Moore, Daniel S. Silverman, and M. Lily Woodland.